All type of patients: 3 trials - Pre-RELAX-AHF - RELAX-AHF - RELAX-AHF-2
serelaxin vs placebo | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
death or hospitalization | no data | Cardiovascular death or hospital admission for CHF | no data | heart failure death | no data | hospitalisation for cardiovascular causes | no data | CV death, MI hospitalization for HF | no data | Cardiovascular death | no data | hospitalisation for heart failure | no data | All cause death | no data | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
Acute heart failure : 1 trials - Pre-RELAX-AHF
serelaxin vs placebo | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
death or hospitalization | no data | Cardiovascular death or hospital admission for CHF | no data | heart failure death | no data | hospitalisation for cardiovascular causes | no data | CV death, MI hospitalization for HF | no data | Cardiovascular death | no data | hospitalisation for heart failure | no data | All cause death | no data | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |